H.C. Wainwright maintains $40 target on GH Research stock
H.C. Wainwright reiterated a Buy rating on shares of GH Research PLC (NASDAQ:GHRS), with a price target of $40.00. Currently ...
H.C. Wainwright ups Akero target after ‘ground-breaking’ data
H.C. Wainwright raised the firm’s price target on Akero Therapeutics (AKRO) to $72 from $50 and keeps a Buy rating on the shares after the ...
H.C. Wainwright sets uniQure stock price target at $70
H.C. Wainwright reaffirmed its confidence in uniQure BV (NASDAQ:QURE), maintaining a Buy rating and significantly raising the price target to $70 from the previous $25. Currently trading at $15.67 ...
HC Wainwright Cuts Lexaria Bioscience (NASDAQ:LEXX) Price Target to $7.00
Lexaria Bioscience (NASDAQ:LEXX – Free Report) had its price target trimmed by HC Wainwright from $10.00 to $7.00 in a report issued on Friday,Benzinga reports. The firm currently has a buy rating on ...
Joplin Globe5h
H.C. Wainwright & Co. Is Once Again Ranked #1 by PlacementTracker
H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume for the calendar year of 2024, maintaining the Firm’s top position for 11 consecutive years in PlacementTracker's Market ...
HC Wainwright Has Positive View of Precigen FY2024 Earnings
Analysts at HC Wainwright boosted their FY2024 earnings estimates for Precigen in a research report issued to clients and investors on Thursday, January 23rd. HC Wainwright analyst S. Ramakanth now ...
bovnews6h
Why Is Cassava Sciences Inc (SAVA) Stock Lagging Behind -67.39% from Its 50-Day SMA?
H.C. Wainwright has recently reduced Cassava Sciences Inc (SAVA) stock to Neutral rating, as announced on November 26, 2024, according to Finviz. Earlier, on October 8, 2024, H.C. Wainwright had ...
bovnews3h
Energy Fuels Inc (UUUU) Stock’s -0.01% Decrease This Year: What’s the Story?
On Friday, Energy Fuels Inc (UUUU) stock saw a decline, ending the day at $5.71 which represents a decrease of $-0.17 or -2.89% from the prior close of $5.88. The stock opened at $5.9 and touched a ...
ArriVent Biopharma price target raised to $39 from $36 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on ArriVent Biopharma (AVBP) to $39 from $36 and keeps a Buy rating on the ...
Nasdaq28d
MetaVia initiated with a Buy at H.C. Wainwright
H.C. Wainwright initiated coverage of MetaVia (MTVA) with a Buy rating and $12 price target The company’s DA-1726 is a novel oxyntomodulin analogue designed as a dual agonist targeting glucagon ...
Nasdaq1mon
HC Wainwright & Co. Initiates Coverage of Worksport (WKSP) with Buy Recommendation
Fintel reports that on January 22, 2025, HC Wainwright & Co. initiated coverage of Worksport (NasdaqCM:WKSP) with a Buy recommendation. As of December 23, 2024, the average one-year price target ...
Monopar Therapeutics price target raised to $40 from $22 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Monopar Therapeutics (MNPR) to $40 from $22 and keeps a Buy rating on the ...